Updates on managing HER2-positive early breast cancer
Updates on managing HER2-positive early breast cancer
Managing HER2-positive breast cancer
Management of axilla after neo-adjuvant treatment
KEYNOTE-598: pembrolizumab with ipilimumab or placebo in patients with untreated metastatic NSCLC
TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair alterations and mCRPC
ASCO GU 2021: Renal cancer roundup
OncoAlert and ecancer weekly roundup for February 07 - 13, 2021
COVID-19 pandemic threatens global life-saving gains in childhood cancer
OncoAlert and ecancer weekly roundup for February 01 - 06, 2021
Latest in EGFR-positive NSCLC with exon 20 insertion mutations
WCLC 2020 overview
Emergence of PARP inhibitors in prostate cancer